Literature DB >> 3724052

Evaluation of the control of Myobia musculi infestations on laboratory mice with permethrin.

D E Bean-Knudsen, J E Wagner, R D Hall.   

Abstract

The efficacy of permethrin against Myobia musculi (Schrank) (Acari:Myobiidae) infestations on mice was evaluated using four different dose delivery methods. In all methods, an attempt was made to deliver 0.5 mg of active permethrin weekly to each mouse. Successful control was achieved with topical or environmental treatment with 0.25% permethrin dust and by dipping the mice into a 0.6 g/l permethrin emulsion. The use of an emulsion applied to the bedding produced the least satisfactory control. Untreated mice had an average infestation rate of 57.3% throughout the study. No significant differences were seen between treated and untreated groups in either body weight or histopathology of the liver, lung, or kidney.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3724052

Source DB:  PubMed          Journal:  Lab Anim Sci        ISSN: 0023-6764


  4 in total

1.  Assessment of immune activation in mice before and after eradication of mite infestation.

Authors:  Nancy A Johnston; Rita A Trammell; Susan Ball-Kell; Steven Verhulst; Linda A Toth
Journal:  J Am Assoc Lab Anim Sci       Date:  2009-07       Impact factor: 1.232

2.  Comparison of a fur mite PCR assay and the tape test for initial and posttreatment diagnosis during a natural infection.

Authors:  Erica E Weiss; Kristin D Evans; Stephen M Griffey
Journal:  J Am Assoc Lab Anim Sci       Date:  2012       Impact factor: 1.232

3.  Comparison of selamectin and imidacloprid plus permethrin in eliminating Leporacarus gibbus infestation in laboratory rabbits (Oryctolagus cuniculus).

Authors:  Leslie L Birke; Patricia E Molina; David G Baker; Stuart T Leonard; Luis J Marrero; Merlin Johnson; Jennifer Simkin
Journal:  J Am Assoc Lab Anim Sci       Date:  2009-11       Impact factor: 1.232

4.  New building, old parasite: Mesostigmatid mites--an ever-present threat to barrier facilities.

Authors:  Julie Watson
Journal:  ILAR J       Date:  2008
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.